News

A MUM has revealed she has no regrets about spending £1,200 on confidence-boosting Mounjaro – despite being in £21,000 of ...
According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...
Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
Berberine, a compound found in various plants, may help to lower blood sugar levels and protect gut health. Available as a ...
New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced st ...
Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.
Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.
A YOUNG woman has revealed that thanks to Mounjaro, she was able to drop down from over 14 stone to just 10 stone in 28 weeks ...
When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...